Search - tctmd.com

Displaying 1 - 20 of 156

Sort: Relevancy | Date

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Daily News

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

Yael L. Maxwell

January 21, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Yael L. Maxwell

October 24, 2025

News Daily News

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Michael O'Riordan

October 10, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

AI-Supported Coaching Shows Promise for Improving Glycemic Control

L.A. McKeown

August 25, 2025

News Daily News

Body Fat Distribution Influences Cardiovascular Age

Todd Neale

August 22, 2025

News Daily News

Healthcare Expenses Increase After GLP-1 Prescription

L.A. McKeown

August 18, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

Caitlin E. Cox

July 21, 2025

News Daily News

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Michael O'Riordan

July 18, 2025

News Daily News

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

Todd Neale

July 14, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Daily News

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Michael O'Riordan

June 13, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

Advertisement

Heart Disease Remains Number One Killer of Americans

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

JACC Debuts Data Digest on CV Health in the United States

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

CVD Still the Leading Cause of Death and Disease Globally

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

AI-Supported Coaching Shows Promise for Improving Glycemic Control

Body Fat Distribution Influences Cardiovascular Age

Healthcare Expenses Increase After GLP-1 Prescription

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Amylin Analogue Boosts Weight Loss When Added to GLP-1

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content